A Novel Cost-Efficient On-Line Intermediate Waveband-Switching Scheme in WDM Mesh Networks

Waveband switching (WBS) is an important technique to save switching and transmission cost in wavelength -division multiplexed (WDM) optical networks. A cost-efficient WBS scheme would enable network carriers to increase the network throughput (revenue) while achieving significant cost savings. We identify the critical factors that determine the WBS network throughput and switching cost and propose a novel intermediate waveband switching (IT-WBS) algorithm, called the minimizing-weighted-cost (MWC) algorithm. The MWC algorithm defines a cost for each candidate route of a call. By selecting the route with the smallest weighted cost, MWC balances between minimizing the call blocking probability and minimizing the network switching cost. Our simulations show that MWC outperforms other wavelength/waveband switching algorithms and can enhance the network throughput at a reduced cost.

A Pilot Study to Determine the Effectiveness of Probiotic Use in Elderly Patients with Antibiotic-Associated Diarrhea

Long-term care settings have the majority of their patients on multiple antibiotics, and outbreaks of antibiotic-associated diarrhea and Clostridium difficile are common. Probiotics have been used with these patients to reduce these side effects. Probiotics can re-establish the composition of intestinal microflora, enhance immune response, and clear pathogens from the host which may reduce the symptoms of antibiotic-associated diarrhea. Therefore, the goal of this study was to conduct a retrospective study of the effectiveness of using probiotic in elderly patients in a long-term care facility in a Midwestern city who suffered from antibiotic-associated diarrhea. The probiotic, CulturelleTM had been administered once a day to eight males and twelve female patients who were taking antibiotics and stool consistency and number were recorded. Out of the original group, seven of the patients receiving the probiotic appeared to have positive effects while two patients had negative effects on stools. Thirteen patients showed no change in stool consistency and number. It was difficult to determine the effects of the probiotic due to the use by the facility of a bowel movement protocol for preventing constipation and impaction, and the lack of dietary records. Published studies in patients in long-term facilities vary greatly in terms of trial design, type and dose of probiotic and duration of treatment, which may explain why probiotics work for some patients and not for others. Probiotic use is becoming more accepted with antibiotic-associated diarrhea but due to the lack of definitive evidence about efficacy and the safety of probiotic use, more studies need to be conducted. Advisors: Kaye Stanek Krogstrand and Julie Albrecht

ACTIVITY OF LM 2219 (DIFETHIALONE), A NEW ANTICOAGULANT RODENTICIDE, IN COMMENSAL RODENTS

ABSTRACT: Preliminary studies completed on commensal rodents with the new anticoagulant rodenticide difethialone showed very good efficacy, such that 25 ppm baits could be used effectively. New test results presented in this publication confirm the activity as shown under laboratory conditions in choice tests, which represent more severe conditions, as well as its effectiveness against rodents that are resistant and non-resistant to warfarin. In tests where the palatability was only fair the chemical activity resulted in excellent mortality. In a field test against a large population of Mus musculus the results proved very satisfactory. Difethialone is toxic to birds and fish. However, it seems to be better tolerated by dogs and pigs, animals that are frequently on the list of accidental poisonings. Difethialone is stored over a prolonged period in the liver but the risk to non-target species consuming rodents having ingested the compound does not seem to be high. For reasons attributed to the mode of action, difethialone must be handled with precautions as other anticoagulants for which Vitamin Kj is the antidote. In the event of an accidental poisoning, an antidotal therapy plan is proposed. The lower levels of active ingredient in finished baits (25 ppm) should pose a low risk to non-target species.